课题基金 / 基金详情

Exploring the immunomodulatory potential of Natural Killer T cells

Exploring the immunomodulatory potential of Natural Killer T cells
探索自然杀伤 T 细胞的免疫调节潜力
批准号:
LP140100920
负责人:
Prof Jamie Rossjohn
金额:
$41.66万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-12-31 至 2018-06-30

项目摘要

项目成果

Prof Jamie Rossjohn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural Killer T cells (NKT cells) are an innate-like population of T cells that recognise a range of lipid based antigens when bound to the antigen-presenting molecule, CD1d. Once activated, NKT cells rapidly secrete a variety of cytokines. This project, in partnership with Vaxine Pty Ltd, aims to gain a basic understanding of NKT recognition of lipids and NKT cell activation by lipids. The project aims to use a combination of cellular immunology and structural biology to gain insight into NKT cell agonism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An investigation into CD1a, a versatile antigen-presenting molecule
  • 批准号:
    DP220102402
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $41.34万
  • 财政年份:
    2022
  • 负责人:
    Prof Jamie Rossjohn
  • 依托单位:
An investigation into T cell immunity towards metabolites
  • 批准号:
    DP220102401
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $52.22万
  • 财政年份:
    2022
  • 负责人:
    Prof Jamie Rossjohn
  • 依托单位:
Investigating the atomic structure of an immune cell inhibitory receptor
  • 批准号:
    LP190101290
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $47.65万
  • 财政年份:
    2020
  • 负责人:
    Prof Jamie Rossjohn
  • 依托单位:
Investigating the structure of a T cell immune checkpoint molecule
  • 批准号:
    LP160101757
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $25.4万
  • 财政年份:
    2017
  • 负责人:
    Prof Jamie Rossjohn
  • 依托单位:
海外基金